MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients

Table 1 Demographic features of study subject n (%)

Characteristics	UC patients	Non IBD control
No. of patients (total)	8	8
Sex (M/F)	3/5	2/6
Age (mean ± SD, range, yr)	39.75 ± 10.29 (25-62)	40.75 ± 11.86 (24-60)
Disease duration (mean ± SD, Range, yr)	6.35 ± 6.52 (1.5-21)	NA
Disease extent
Proctitis	3 (37.5)
Left sided colitis	5 (62.5)
Medication
Mesalamine	5 (62.5)	0
Azathioprine	3 (37.5)	0
Steroids	0	0

UC: Ulcerative colitis; IBD: Inflammatory bowel disease.